Galderma Laboratories Revenue, Growth & Competitor Profile

DBA GALDERMA SERVICES, INC.
DBA NESTLE SKIN HEALTH U.S., INC.
DBA NSH SERVICES INC.

Company Profile & Annual Report for Galderma Laboratories

Access the complete profile.

Galderma Laboratories Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	2001 Ross Ave 16th Floor Dallas, TX 75201

Note: Revenues for privately held companies are statistical evaluations.


Galderma Laboratories's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Galderma Laboratories's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Galderma Laboratories is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Galderma Laboratories Annual Revenue and Growth Rate

Galderma Laboratories	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Galderma Laboratories's revenues are gauged from an analysis of company filings.

Galderma Laboratories's Income Statement (based on Industry Averages)

Galderma Laboratories P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Galderma Laboratories is developing and marketing. Galderma Laboratories doesn't have any recent trademark applications, indicating Galderma Laboratories is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EFRACEA Pharmaceutical preparations for the treatment of dermatological diseases and conditions	09/22/2009
RESTORADERM Non-medicated skin care preparations	07/06/2007
CGPI Pharmaceutical, medical and veterinary preparations, namely oral and topical drugs for the treatment of inflammatory disorders of the skin, including acne, rosacea, dermatitis, psoriasis, excema and related disorders	04/12/2006

See all trademarks and details in the Full Report.

Market Share of Galderma Laboratories's Largest Competitors

A competitive analysis shows these companies are in the same general field as Galderma Laboratories, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Galderma Laboratories. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GALDERMA LABORATORIES	Dallas, TX	100
INSTIL BIO	Dallas, TX	7
INFRATECH	Dallas, TX	1
TOPMD	Dallas, TX	1

Future Competition: Galderma Laboratories's Fastest Growing Competitors

These companies are in the same general field as Galderma Laboratories and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)